Target intelligence / Profile preview

Two-pore calcium channel protein (TPC) (TPC)

Target
TPC
Molecular classification
Ion channel, Receptor
01

Overview

The NAADP-sensitive receptor, primarily identified as the Two-pore calcium channel protein (TPC) family (specifically TPCN1 and TPCN2), is a class of intracellular ion channels located on acidic organelles such as endosomes and lysosomes (UniProt Q8NHX9, Q9ULQ1). These channels are activated by nicotinic acid adenine dinucleotide phosphate (NAADP), the most potent known calcium-mobilizing second messenger (Galione, 2015). Recent evidence suggests that NAADP does not bind directly to TPCs but acts through accessory proteins like JPT2 and LSM12 to trigger channel opening (Gunaratne et al., 2021). This signaling pathway is essential for endolysosomal trafficking, autophagy, and nutrient sensing, and its disruption is linked to metabolic diseases like diabetes and fatty liver disease. In infectious disease, TPCs are required for the endosomal escape and entry of viruses such as Ebola and SARS-CoV-2 (Sakurai et al., 2015). Pharmacological inhibitors like tetrandrine and Ned-19 have been shown to block these processes, making the NAADP-sensitive receptor a significant target for antiviral and metabolic therapies (Naylor et al., 2009).

Other names
Nicotinic acid adenine dinucleotide phosphate receptorTPCN1TPCN2Two-pore channelNAADP receptor
02

Mechanism of action

Antagonism of NAADP-mediated calcium release from acidic organelles by either blocking the NAADP binding site on accessory proteins (like JPT2) or inhibiting the TPC channel pore directly.

03

Biological functions

Signal transductionCalcium signalingAutophagyEndolysosomal traffickingNutrient sensing
04

Disease associations

InfectionDiabetesCancerNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Lysosomal storage dysfunctionInhibition of autophagyAlteration of glucose and lipid metabolismPotential off-target effects on other calcium channels
06

Interacting drugs

Ned-19

4 more in the full profile.

07

Biomarkers

TPCN2 expression levelsLysosomal calcium fluxNAADP concentrationLysosomal pH

Beyond the preview

Go deeper on Two-pore calcium channel protein (TPC) (TPC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Two-pore calcium channel protein (TPC) (TPC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call